Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →
The proof-of-concept study involved only two patients.
The story didn’t tell readers this was an observational study–cause-and-effect couldn’t be established.
The story is full of holes and canned quotes, making the news release more informative.
The release is also very transparent about potential conflicts of interest.
There’s an emerging assumption that fermented dairy products might be “pro-biotic” and, therefore, “heart-friendly.” But, at this time, that remains purely speculative.
The release appropriately noted that the test needs validation through a larger study.
When it comes to ketamine, people with depression and their families should be informed of the unclear benefits and risks.
Also, the story states that Xofluza is associated with fewer side effects than Tamiflu, but it doesn’t mention any potential harms.
Tips & Resources for Analyzing Health Care Claims